Global pharma major Lupin Limited on Friday announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Canagliflozin Tablets, 100 mg and 300 mg. According to a press statement, the approval has been granted to market a generic equivalent of Invokana … Read more
Global pharma major Lupin Limited recently announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Apalutamide Tablets, 60 mg. Approval is granted to market a generic equivalent of Erleada Tablets, 60 mg of Janssen Biotech, Inc. This product will be … Read more
•Fixed Income: The New 10-Year Benchmark GOI 7.18 2033 traded between 7.28% – 7.39% during this week Old 10-Year Benchmark GOI 7.26 2033 traded between 7.34% – 7.45% during this week, tracking movement in Crude Oil, Currency, US Treasury Yields and Inflation data. •Auction Highlights RBI conducted the Auction for G-sec, SDL, and T-Bill for … Read more